HGF and MET: From Brain Development to Neurological Disorders.
HGF and MET: From Brain Development to Neurological Disorders.
复制标题
DOI:
10.3389/fcell.2021.683609
复制
发表时间:
2021
影响因子:
5.5
通讯作者:
Crepaldi T
中科院分区:
文献类型:
--
作者:
Desole C;Gallo S;Vitacolonna A;Montarolo F;Bertolotto A;Vivien D;Comoglio P;Crepaldi T
Hepatocyte growth factor (HGF) and its tyrosine kinase receptor, encoded by the MET cellular proto-oncogene, are expressed in the nervous system from pre-natal development to adult life, where they are involved in neuronal growth and survival. In this review, we highlight, beyond the neurotrophic action, novel roles of HGF-MET in synaptogenesis during post-natal brain development and the connection between deregulation of MET expression and developmental disorders such as autism spectrum disorder (ASD). On the pharmacology side, HGF-induced MET activation exerts beneficial neuroprotective effects also in adulthood, specifically in neurodegenerative disease, and in preclinical models of cerebral ischemia, spinal cord injuries, and neurological pathologies, such as Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS), and multiple sclerosis (MS). HGF is a key factor preventing neuronal death and promoting survival through pro-angiogenic, anti-inflammatory, and immune-modulatory mechanisms. Recent evidence suggests that HGF acts on neural stem cells to enhance neuroregeneration. The possible therapeutic application of HGF and HGF mimetics for the treatment of neurological disorders is discussed.
登录
查看更多内容
DOI:
10.1016/s0165-3806(97)00108-9
发表时间:
1997-09-20
期刊:
DEVELOPMENTAL BRAIN RESEARCH
影响因子:
--
作者:
Achim, CL;Katyal, S;Michalopoulos, GK
通讯作者:
Michalopoulos, GK
影响因子:
8
作者:
Campbell, Daniel B.;Buie, Timothy M.;Levitt, Pat
通讯作者:
Levitt, Pat
影响因子:
5.1
作者:
Aoki, M;Morishita, R;Ogihara, T
通讯作者:
Ogihara, T
影响因子:
25
作者:
通讯作者:
--
影响因子:
56.9
作者:
BOTTARO, DP;RUBIN, JS;AARONSON, SA
通讯作者:
AARONSON, SA